Draft:Andre Rosowsky
Submission declined on 10 December 2023 by Ldm1954 (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Submission declined on 8 December 2023 by Alalch E. (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
The content of this submission includes material that does not meet Wikipedia's minimum standard for inline citations. Please cite your sources using footnotes. For instructions on how to do this, please see Referencing for beginners. Thank you. Declined by Alalch E. 5 months ago. |
- Comment: Please read carefully the guidelines for academics in WP:NPROF. While he has had a good career, there is nothing in this draft that meets those criteria. Does he have any major awards? Major interviews or other news items? Just publishing papers or being on grants/panels/editorial boards is not enough. Maybe you can focus on some of these and try again. Ldm1954 (talk) 14:20, 10 December 2023 (UTC)
Dr. Andre Rosowsky is a retired associate professor who spent more than 40 years as a research faculty member of the Dana-Farber Cancer Institute and Harvard Medical School, and simultaneously for a number of years as an adjunct faculty member at Northeastern University, all in Boston, Massachusetts.
Born in France in 1936, he came to the U.S. to live with an aunt and uncle in 1947 as the son of Nazi holocaust victims. He earned a B.S. degree in chemistry at the University of California (Berkeley) in 1957 and a Ph.D. in organic chemistry at the University of Rochester as an Abbott Fellow under the supervision of Professor D.S. Tarbell in 1961[1], then spent a year as National Science Foundation Fellow at Harvard University in the laboratory of Professor and eventual Nobel Prize winner E.J. Corey.
In addition to being the principal author or a co-author of more than 350 scientific articles [2][3][4][5][6][7], meeting abstracts, and book chapters, as well as being the principal inventor or co-inventor of more than twenty U.S and foreign patents [8], he is a former Editorial Board member of the Journal of Medicinal Chemistry and of the specialized international journal Pteridines, and was the editor of a volume in the celebrated multi-volume book series “Heterocyclic Compounds”. He also served for the maximum allowed time on three grant-review Study Sections (ET-1, ET-2, ARRD) of the National Institutes of Health (NIH), enabling laboratory and administrative support for numerous investigators in the cancer and AIDS fields.
He is chiefly known for the chemical synthesis and preclinical evaluation of novel dihydrofolate reductase (DHFR) inhibitors as potential anticancer and antiparasitic agents. One of these, originally code-named PT523 and later known as talotrexin, was patented and underwent a commercially sponsored and federally approved Phase 1 clinical trial in which favorable responses were observed in a number of patients [9]. Before further commercial development had the opportunity to be carried out, he retired in 2008 at the age of seventy-two.
References[edit]
- ^ https://www.sas.rochester.edu/chm/assets/files/newsletter/newsletter16.pdf
- ^ "CanJChem54,3757(76)".
- ^ "ActaCryst,D58,946(02)".
- ^ "Chemical and biological studies on 1,2-dihydro-s-triazines. XIX. A nuclear magnetic resonance investigation of hindered internal rotation in 1-aryl derivatives".
- ^ "Rosowsky A - Search Results - PubMed". PubMed.
- ^ "Andre Rosowsky". scholar.google.com.
- ^ "Andre ROSOWSKY | Associate Professor (Retired) | Ph.D. | Dana-Farber Cancer Institute, Boston | DFCI | Department of Medical Oncology | Research profile - Page 5".
- ^ "Patents Assigned to Dana-Farber Cancer Institute, Inc. - Justia Patents Search". patents.justia.com.
- ^ "5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism".
- meet any of the eight academic-specific criteria
- or cite multiple reliable, secondary sources independent of the subject, which cover the subject in some depth
Make sure your draft meets one of the criteria above before resubmitting. Learn about mistakes to avoid when addressing this issue. If the subject does not meet any of the criteria, it is not suitable for Wikipedia.